We are live on
!
Find out more
SC
Samlyn Capital Portfolio holdings
AUM
$5.86B
1-Year Est. Return
36.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.47%
1 Year Est. Return
+36.3%
3 Year Est. Return
+115.4%
5 Year Est. Return
+175.71%
10 Year Est. Return
+881.8%
AUM
$4.41B
AUM Growth
+$210M
(+5%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
2.33%
Top 10 Holdings %
Top 10 Hldgs %
26.78%
Holding
169
New
57
Increased
32
Reduced
27
Closed
51
Top Buys
| 1 |
American Express
AXP
|
+$106M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$105M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$74.4M |
| 4 |
TJX Companies
TJX
|
+$72.2M |
| 5 |
Comcast
CMCSA
|
+$69.7M |
Top Sells
| 1 |
Aramark
ARMK
|
+$98.9M |
| 2 |
K
Kellanova
K
|
+$91.7M |
| 3 |
Valero Energy
VLO
|
+$82.2M |
| 4 |
Bank of America
BAC
|
+$74.8M |
| 5 |
Canadian Natural Resources
CNQ
|
+$72.6M |
Sector Composition
| 1 | Healthcare | 23.14% |
| 2 | Financials | 22.52% |
| 3 | Consumer Discretionary | 17.14% |
| 4 | Consumer Staples | 10.49% |
| 5 | Industrials | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
PUT
Gentex
GNTX
$5.3B
| $4.92M | 0.11% |
+250,000
| New | +$4.55M |
|
102
Nabors Industries
NBR
$1.22B
| $4.65M | 0.11% |
+5,666
| New | +$3.99M |
|
103
Take-Two Interactive
TTWO
$44.5B
| $4.35M | 0.1% |
+88,207
| New | +$4.17M |
|
104
Restaurant Brands International
QSR
$26.8B
| $4.33M | 0.1% |
+90,745
| New | +$4.19M |
|
105
Kirby Corp
KEX
$7.67B
| $4.25M | 0.1% |
63,971
-288,929
| -82% | -$18.3M |
|
|
SAGE
106
DELISTED
Sage Therapeutics
SAGE
| $4.19M | 0.09% |
+82,000
| New | +$3.87M |
|
|
ALXN
107
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.16M | 0.09% |
+34,000
| New | +$4.16M |
|
108
Pacira BioSciences
PCRX
$1.01B
| $4.1M | 0.09% |
+127,000
| New | +$4.24M |
|
|
MNTA
109
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.97M | 0.09% |
+264,000
| New | +$3.49M |
|
|
NVRO
110
DELISTED
NEVRO CORP.
NVRO
| $3.92M | 0.09% |
+54,000
| New | +$4.62M |
|
111
Ionis Pharmaceuticals
IONS
$9.03B
| $3.87M | 0.09% |
+81,000
| New | +$3.21M |
|
112
Ultragenyx Pharmaceutical
RARE
$2.98B
| $3.87M | 0.09% |
+55,000
| New | +$3.9M |
|
|
DERM
113
DELISTED
Dermira, Inc.
DERM
| $3.85M | 0.09% |
+127,000
| New | +$4.09M |
|
114
Vertex Pharmaceuticals
VRTX
$123B
| $3.83M | 0.09% |
+52,000
| New | +$4.23M |
|
115
Incyte
INCY
$23.3B
| $3.81M | 0.09% |
+38,000
| New | +$3.71M |
|
|
ALDR
116
DELISTED
Alder Biopharmaceuticals
ALDR
| $3.74M | 0.08% |
+180,000
| New | +$4.68M |
|
117
Aclaris Therapeutics
ACRS
$749M
| $3.69M | 0.08% |
+136,000
| New | +$3.47M |
|
|
COOP
118
DELISTED
Mr. Cooper
COOP
| $83K | ﹤0.01% |
4,452
| – | – |
|
119
American Eagle Outfitters
AEO
$2.93B
| – | – |
-156,073
| Closed | -$2.79M |
|
120
CALL
Boeing
BA
$169B
| – | – |
-80,000
| Closed | -$10.5M |
|
121
Alibaba
BABA
$282B
| – | – |
-73,646
| Closed | -$7.79M |
|
|
122
Bank of America
BAC
$432B
| – | – |
-4,776,904
| Closed | -$74.8M |
|
123
Bath & Body Works
BBWI
$4.26B
| – | – |
-53,511
| Closed | -$3.06M |
|
124
Best Buy
BBY
$18B
| – | – |
-236,450
| Closed | -$9.03M |
|
125
Booking.com
BKNG
$143B
| – | – |
-127,875
| Closed | -$7.53M |
|
Similar funds
LIP
JSSH
CIC
BSL
MWM
TCM
VAM
WAM
Samlyn Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Samlyn Capital held 169 positions worth $4.41B, up 5% from $4.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Samlyn Capital's Q4 2016 filing shows 57 new, 32 increased, 27 reduced and 51 closed positions. Its largest new stake was American Express: 1,526,176 shares worth $113M. The largest sale was Aramark, an estimated $98.9M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Samlyn Capital's largest Q4 2016 buy was American Express: 1,526,176 shares worth $113M.
- Samlyn Capital added most to Envision Healthcare Holdings Inc in Q4 2016, an estimated $74.4M increase.
- Samlyn Capital's biggest Q4 2016 reduction was Aramark, cutting an estimated $98.9M.
- Samlyn Capital fully exited Kellanova in Q4 2016, selling an estimated $91.7M.
- Samlyn Capital's ten largest holdings make up 27% of its $4.41B portfolio in Q4 2016.
- Samlyn Capital opened 57 new positions and closed 51 in Q4 2016.
- Samlyn Capital's portfolio value rose 5% quarter-over-quarter to $4.41B.
Based on Samlyn Capital's 13F filing for Q4 2016, filed 14 Feb 2017.